TY - JOUR
T1 - The Evidence for Antimicrobial and Hard to Infect Regenerative Matrices
AU - Ray, Keval
AU - Khajoueinejad, Nazanin
AU - Park, So
AU - Chan, Mabel
AU - Lee, Jani
AU - Lantis, John C.
PY - 2021/12/6
Y1 - 2021/12/6
N2 - Preparation of the wound bed is a key step in the use of cell- and tissue-based therapy (CTP). In particular, good pre-application debridement is an essential component of CTP. However, there are many situations in which the wound bed is not adequately debrided, including trauma, burn, and in cases of chronic wounds with significant biofilm. In the setting of inadequate wound bed preparation, the use of a CTP that has either added or intrinsic antimicrobial properties is attractive. Some CTPs include added antimicrobial agents such as PHMB or silver, while others have intrinsic antimicrobial components, such as Omega 3 fatty acids. In addition, some wound-covering dressings are completely synthetic, and therefore simply do not become infected. A full understanding of the basic science and clinical data supporting the use of these therapies is important for the advanced wound care practitioner.
AB - Preparation of the wound bed is a key step in the use of cell- and tissue-based therapy (CTP). In particular, good pre-application debridement is an essential component of CTP. However, there are many situations in which the wound bed is not adequately debrided, including trauma, burn, and in cases of chronic wounds with significant biofilm. In the setting of inadequate wound bed preparation, the use of a CTP that has either added or intrinsic antimicrobial properties is attractive. Some CTPs include added antimicrobial agents such as PHMB or silver, while others have intrinsic antimicrobial components, such as Omega 3 fatty acids. In addition, some wound-covering dressings are completely synthetic, and therefore simply do not become infected. A full understanding of the basic science and clinical data supporting the use of these therapies is important for the advanced wound care practitioner.
UR - http://www.scopus.com/inward/record.url?scp=85122530017&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85122530017&partnerID=8YFLogxK
U2 - 10.52198/21.STI.39.WH1476
DO - 10.52198/21.STI.39.WH1476
M3 - Article
C2 - 34872156
AN - SCOPUS:85122530017
SN - 1090-3941
VL - 39
SP - 75
EP - 82
JO - Surgical technology international
JF - Surgical technology international
ER -